{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:29:26Z","timestamp":1790270966901,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17"],"award-info":[{"award-number":["PI17"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Georgina Petropoulos Nouna"},{"name":"Instituto de Salud Carlos III (ISCIII), Acci\u00f3n Estrat\u00e9gica en Salud"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ejim.2019.08.005","type":"journal-article","created":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T10:35:36Z","timestamp":1566038136000},"page":"14-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["3P association (3PAs): Pituitary adenoma and pheochromocytoma\/paraganglioma. A heterogeneous clinical syndrome associated with different gene mutations"],"prefix":"10.1016","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4165-4356","authenticated-orcid":false,"given":"Fernando","family":"Guerrero-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Fajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Torres Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Gim\u00e9nez-Palop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Lisbona Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2834-4385","authenticated-orcid":false,"given":"Tomas","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natividad","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"D\u00edez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0126-1985","authenticated-orcid":false,"given":"Pedro","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Robledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Villabona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejim.2019.08.005_bb0005","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2019.08.005_bb0010","series-title":"Williams Textbook of Endocrinology","first-page":"1724","article-title":"Multiple endocrine neoplasia","author":"Stewart","year":"2016"},{"key":"10.1016\/j.ejim.2019.08.005_bb0015","doi-asserted-by":"crossref","first-page":"E710","DOI":"10.1210\/jc.2014-4297","article-title":"Pituitary adenoma with paraganglioma\/ pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice","volume":"100","author":"Xekouki","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2019.08.005_bb0020","doi-asserted-by":"crossref","first-page":"T105","DOI":"10.1530\/ERC-15-0241","article-title":"15 years of paraganglioma: the association of pituitary adenomas and phaeochromocytomas or paragangliomas","volume":"22","author":"O'Toole","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ejim.2019.08.005_bb0025","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1210\/js.2017-00135","article-title":"Case report of a prolactinoma in a patient with a novel MAX mutation and bilateral pheochromocytoma","volume":"23","author":"Roszko","year":"2017","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.ejim.2019.08.005_bb0030","doi-asserted-by":"crossref","first-page":"L37","DOI":"10.1530\/ERC-18-0065","article-title":"Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions","volume":"25","author":"Daly","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ejim.2019.08.005_bb0035","article-title":"The 3PAs: an update on the association of Pheochromocytomas, paragangliomas, and pituitary tumors","author":"Xekouki","year":"2018","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ejim.2019.08.005_bb0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.arr.2014.05.004","article-title":"Krebs cycle intermediates regulate DNA and histone methylation: epigenetic impact on the aging process","volume":"16","author":"Salminen","year":"2014","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.ejim.2019.08.005_bb0045","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/PAP.0b013e31825c6bc6","article-title":"Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications","volume":"19","author":"Barletta","year":"2012","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.ejim.2019.08.005_bb0050","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/gim.2014.162","article-title":"Toward an improved definition of the genetic and tumor spectrum associated with SDH germ-line mutations","volume":"17","author":"Evenepoel","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.ejim.2019.08.005_bb0055","doi-asserted-by":"crossref","first-page":"E531","DOI":"10.1210\/jc.2014-3399","article-title":"Heterogeneous genetic background of the association of pheochromocytoma\/paraganglioma and pituitary adenoma: results from a large patient cohort","volume":"100","author":"D\u00e9nes","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2019.08.005_bb0060","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jmoldx.2017.04.009","article-title":"PheoSeq: a targeted next-generation sequencing assay for pheochromocytoma and paraganglioma diagnostics","volume":"19","author":"Curr\u00e1s-Freixes","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.ejim.2019.08.005_bb0065","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/modpathol.2015.41","article-title":"SDHB\/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a multinational study of the European network for the study of adrenal Tumors (ENS@T)","volume":"28","author":"Papathomas","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejim.2019.08.005_bb0070","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.endonu.2016.07.007","article-title":"Pituitary adenoma associated with pheochromocytoma\/paraganglioma: a new form of multiple endocrine neoplasia","volume":"63","author":"Guerrero P\u00e9rez","year":"2016","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.ejim.2019.08.005_bb0075","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.endonu.2012.02.009","article-title":"Coexistence of a pituitary macroadenoma and multicentric paraganglioma: a strange coincidence","volume":"60","author":"Varsavsky","year":"2013","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.ejim.2019.08.005_bb0080","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cncr.20412","article-title":"The prevalence of pituitary adenomas: a systematic review","volume":"101","author":"Ezzat","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ejim.2019.08.005_bb0085","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","article-title":"High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2019.08.005_bb0090","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1210\/jc.2010-0537","article-title":"Incidence of pituitary adenomas in northern Finland in 1992-2007","volume":"95","author":"Raappana","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2019.08.005_bb0095","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11102-012-0454-0","article-title":"Prevalence and incidence of pituitary adenomas: a population based study in Malta","volume":"16","author":"Gruppetta","year":"2013","journal-title":"Pituitary"},{"key":"10.1016\/j.ejim.2019.08.005_bb0100","first-page":"2172","article-title":"Epidemiology of pituitary adenoma: results of the first Swiss study","volume":"28","author":"Fontana","year":"2009","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.ejim.2019.08.005_bb0105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ecl.2017.01.004","article-title":"Genetic aspects of pituitary adenomas","volume":"46","author":"Marques","year":"2017","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ejim.2019.08.005_bb0110","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jso.23157","article-title":"Hereditary pheochromocytoma and paraganglioma","volume":"106","author":"Mazzaglia","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejim.2019.08.005_bb0115","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1373\/clinchem.2012.182246","article-title":"Pheochromocytoma","volume":"59","author":"Eisenhofer","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.ejim.2019.08.005_bb0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/his.13402","article-title":"Pathology and genetics of phaeochromocytoma and paraganglioma","volume":"72","author":"Turchini","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.ejim.2019.08.005_bb0125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.critrevonc.2016.01.022","article-title":"Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era","volume":"100","author":"Pillai","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejim.2019.08.005_bb0130","article-title":"The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes","volume":"24","author":"Udager","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejim.2019.08.005_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0954-6820.1952.tb13837.x","article-title":"Acromegaly associated with phaeochromocytoma","volume":"142","author":"Iversen","year":"1952","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.ejim.2019.08.005_bb0140","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1210\/jc.2004-1759","article-title":"Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism","volume":"90","author":"Frank-Raue","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2019.08.005_bb0145","article-title":"Phaeochromocytoma and acromegaly: a unifying diagnosis","volume":"2014","author":"Mumby","year":"2014","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.ejim.2019.08.005_bb0150","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1210\/jcem-63-6-1421","article-title":"Acromegaly and phaeochromocytoma: a multiple endocrine syndrome caused by a plurihormonal adrenal medullary tumor","volume":"63","author":"Roth","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2019.08.005_bb0155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12022-007-0006-8","article-title":"Acromegaly secondary to growth hormone-releasing hormone secreted by an incidentally discovered pheochromocytoma","volume":"18","author":"Vieira Neto","year":"2007","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.ejim.2019.08.005_bb0160","first-page":"268ra177","article-title":"Recurrent epimutation of SDHC in gastrointestinal stromal tumors","volume":"24","author":"Killian","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ejim.2019.08.005_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/hed.23420","article-title":"Unusual case of Cowden-like syndrome, neck paraganglioma, and pituitary adenoma","volume":"36","author":"Efstathiadou","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.ejim.2019.08.005_bb0170","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1590\/S0004-27302012000800008","article-title":"Genetic studies in a coexistence of acromegaly, pheochromocytoma, gastrointestinal stromal tumor (GIST) and thyroid follicular adenoma","volume":"56","author":"Boguszewski","year":"2012","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.ejim.2019.08.005_bb0175","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.bbabio.2011.07.003","article-title":"SDH mutations in cancer","volume":"1807","author":"Bardella","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ejim.2019.08.005_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-13-0623","article-title":"Non-pheochromocytoma (PCC)\/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis","volume":"170","author":"Papathomas","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejim.2019.08.005_bb0185","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1530\/EJE-17-0523","article-title":"Diagnosis of endocrine disease: SDHx mutations: beyond pheochromocytomas and paragangliomas","volume":"78","author":"Mannelli","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejim.2019.08.005_bb0190","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.292.8.943","article-title":"Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations","volume":"292","author":"Neumann","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2019.08.005_bb0195","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10689-014-9725-4","article-title":"Exploring the association of succinate dehydrogenase complex mutations with lymphoid malignancies","volume":"13","author":"Renella","year":"2014","journal-title":"Fam Cancer"},{"key":"10.1016\/j.ejim.2019.08.005_bb0200","doi-asserted-by":"crossref","first-page":"E1386","DOI":"10.1210\/jc.2015-2689","article-title":"Succinate dehydrogenase (SDH)-deficient pancreatic neuroendocrine tumor expands the SDH-related tumor Spectrum","volume":"100","author":"Niemeijer","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2019.08.005_bb0205","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/PAT.0b013e3283486bb9","article-title":"Adenomatoid tumour of the adrenal gland in a patient with germline SDHD mutation: a case report and review of the literature","volume":"43","author":"Limbach","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.ejim.2019.08.005_bb0210","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1365-2265.2008.03368.x","article-title":"SDHC mutation in an elderly patient without familial antecedents","volume":"69","author":"L\u00f3pez-Jim\u00e9nez","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ejim.2019.08.005_bb0215","doi-asserted-by":"crossref","first-page":"E357","DOI":"10.1210\/jc.2011-1179","article-title":"Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH?","volume":"97","author":"Xekouki","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2019.08.005_bb0220","doi-asserted-by":"crossref","first-page":"E1103","DOI":"10.1210\/jc.2013-1400","article-title":"Familial SDHA mutation associated with pituitary adenoma and pheochromocytoma\/ paraganglioma","volume":"98","author":"Dwight","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2019.08.005_bb0225","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/PAS.0000000000000149","article-title":"Succinate dehydrogenase deficiency is rare in pituitary adenomas","volume":"38","author":"Gill","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejim.2019.08.005_bb0230","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12022-017-9474-7","article-title":"Pituitary carcinoma in a patient with an SDHB mutation","volume":"28","author":"Tufton","year":"2017","journal-title":"Endocr Pathol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620519302766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620519302766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:29:53Z","timestamp":1760606993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620519302766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":46,"alternative-id":["S0953620519302766"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2019.08.005","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3P association (3PAs): Pituitary adenoma and pheochromocytoma\/paraganglioma. A heterogeneous clinical syndrome associated with different gene mutations","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2019.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}